LOW COPY NUMBER AND LIMITED VARIABILITY OF PROVIRAL DNA IN ALVEOLAR MACROPHAGES FROM HIV-1-INFECTED PATIENTS - EVIDENCE FOR GENETIC-DIFFERENCES IN HIV-1 BETWEEN LUNG AND BLOOD MACROPHAGE POPULATIONS

被引:59
作者
NAKATA, K
WEIDEN, M
HARKIN, T
HO, D
ROM, WN
机构
[1] NYU,MED CTR,DIV PULM & CRIT CARE MED,NEW YORK,NY 10016
[2] NYU,MED CTR,BELLEVUE CHEST SERV,NEW YORK,NY 10016
[3] AARON DIAMOND AIDS RES CTR,NEW YORK,NY
关键词
D O I
10.1007/BF03401889
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: We investigated the human immunodeficiency virus (HN proviral DNA sequence and copy number in alveolar macrophages (AM) and peripheral blood monocytes (PBM from 10 HIV-positive patients without any active concurrent pulmonary disease to understand the nature of HIV-1 infection in vivo in the lung microenvironment. Materials and Methods: The 10 seropositive patients without active pulmonary disease were selected based on chest roentegenography and pathological/cytological tests of bronchoalveolar (BAL) fluid. Ln order to determine accurate proviral copy numbers, AM and PBM were isolated to 99 and 94% purity, respectively, and quantitative polymerase chain reaction (PCR), with a sensitivity to detect three copies of HIV proviral DNA per 10(5) cells, was applied. For analysis of genetic variation in HIV-1, PCR-amplified HIV-1 DNA from AM and PBM of five patients were subcloned and 2-12 clones from each sample underwent DNA sequence analysis of HIV-1 gp120 V3-V5. Heteroduplex mobility assays were performed to confirm the results of the sequence analysis. Results: The proviral copy number in AM or PBM were less than 20 copies/10(5) sells in all patients, and five patients had less than the detection limit. There was no significant difference in HIV copy number between AM and PRM. No correlation was found between PBM/AM HN copy number and CD4(+) lymphocyte count in the peripheral blood. Sequence analysis revealed that the mean intrapatient genetic similarity in AM was 97.5 +/- 0.18% (n = 107), which was significantly higher than that in PBM (96.2 +/- 0.26% (n = 94), p < 0.001), suggesting that variability of HIV-1 DNA in AM was relatively limited. Divergence occurred when AM derived HIV-1 sequence was compared with PBM derived sequence from the same patient (95.8 +/- 0.17% (n 223) p < 0.001). Phylogenetic analysis of DNA sequence demonstrated complete separation of HIV lineages from lung and blood in four of five patients, Conclusions: The results suggest that HIV-1 infection in AM is restricted in vivo with low Viral burden and homogenous genotype. We propose that the pulmonary microenvironment may limit the extent of HIV-1 infection.
引用
收藏
页码:744 / 757
页数:14
相关论文
共 51 条
[41]  
SIERRAMADERO JG, 1994, J INFECT DIS, V169, P18, DOI 10.1093/infdis/169.1.18
[42]   EVIDENCE FOR A ROLE OF VIRULENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) VARIANTS IN THE PATHOGENESIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME - STUDIES ON SEQUENTIAL HIV ISOLATES [J].
TERSMETTE, M ;
GRUTERS, RA ;
DEWOLF, F ;
DEGOEDE, REY ;
LANGE, JMA ;
SCHELLEKENS, PTA ;
GOUDSMIT, J ;
HUISMAN, HG ;
MIEDEMA, F .
JOURNAL OF VIROLOGY, 1989, 63 (05) :2118-2125
[43]   SPONTANEOUS PRODUCTION OF INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS [J].
TRENTIN, L ;
GARBISA, S ;
ZAMBELLO, R ;
AGOSTINI, C ;
CAENAZZO, C ;
DIFRANCESCO, C ;
CIPRIANI, A ;
FRANCAVILLA, E ;
SEMENZATO, G .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) :731-737
[44]   ENHANCED ACCESSORY CELL-FUNCTION BY ALVEOLAR MACROPHAGES FROM PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS - POTENTIAL ROLE FOR DEPLETION OF CD4+ CELLS IN THE LUNG [J].
TWIGG, HL ;
LIPSCOMB, MF ;
YOFFE, B ;
BARBARO, DJ ;
WEISSLER, JC .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1989, 1 (05) :391-400
[45]  
TWIGG HL, 1992, J IMMUNOL, V149, P1462
[46]  
van Furth R, 1989, Curr Top Pathol, V79, P125
[47]   ORIGIN AND TURNOVER OF ALVEOLAR MACROPHAGES IN EXPERIMENTAL PNEUMONIA [J].
VELO, GP ;
SPECTOR, WG .
JOURNAL OF PATHOLOGY, 1973, 109 (01) :7-&
[48]   MACROPHAGE TROPISM DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO [J].
WESTERVELT, P ;
TROWBRIDGE, DB ;
EPSTEIN, LG ;
BLUMBERG, BM ;
LI, YX ;
HAHN, BH ;
SHAW, GM ;
PRICE, RW ;
RATNER, L .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2577-2582
[49]   CELLULAR-LOCALIZATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION WITHIN THE BRAINS OF ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME PATIENTS [J].
WILEY, CA ;
SCHRIER, RD ;
NELSON, JA ;
LAMPERT, PW ;
OLDSTONE, MBA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (18) :7089-7093
[50]   MYCOBACTERIUM-TUBERCULOSIS ENHANCES HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION BY TRANSCRIPTIONAL ACTIVATION AT THE LONG TERMINAL REPEAT [J].
ZHANG, YH ;
NAKATA, K ;
WEIDEN, M ;
ROM, WN .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2324-2331